Cart
sales@molnova.com
Elenbecestat (b)
CAS No. 1388149-39-0
Elenbecestat (b)( E2609 | E-2609 )
Catalog No. M11611 CAS No. 1388149-39-0
Elenbecestat (E2609) is a novel potent, oral BACE1 inhibitor for treatment of Alzheimer's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1593 | Get Quote |
|
| 50MG | 3222 | Get Quote |
|
| 100MG | 4410 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameElenbecestat (b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionElenbecestat (E2609) is a novel potent, oral BACE1 inhibitor for treatment of Alzheimer's disease.
-
DescriptionElenbecestat (E2609) is a novel potent, oral BACE1 inhibitor for treatment of Alzheimer's disease.Alzheimer's Disease Phase 3 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsE2609 | E-2609
-
PathwayMetabolic Enzyme/Protease
-
TargetBACE
-
RecptorBACE
-
Research AreaNeurological Disease
-
IndicationAlzheimer Disease
Chemical Information
-
CAS Number1388149-39-0
-
Formula Weight491.4124
-
Molecular FormulaC19H15F6N5O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC(F)C1=CN=C(C(NC2=CC=C(F)C([C@]3(CO[C@@H]4C(F)(F)F)[C@]4([H])CSC(N)=N3)=C2)=O)C=N1
-
Chemical NameN-(3-((4aS,5S,7aS)-2-amino-5-(trifluoromethyl)-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl)-4-fluorophenyl)-5-(difluoromethyl)pyrazine-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
LY2886721
LY2886721 is a highly potent, selective BACE1 aspartyl protease inhibitor with IC50 of 20.3 and 10.2 nM for BACE1 and BACE2.
-
Isorubrofusarin-6-O-...
Isorubrofusarin-6-O-β-gentiobioside is derived from from Cassia obtusifolia Linn seeds and shows promising inhibitory activity against AChE and BACE1.
-
PF-06751979
PF-06751979 is a potent, selective, brain penetrant BACE1 inhibitor with binding IC50 of 7.3, 27-fold selectivity over BACE2.
